سامانه مدیریت نشریات علمی دانشگاه علوم پزشکی مشهد

Noei Razliqi, Reza, Harooni, Elnaz, Neisi, Niloofar, Jafar Sameri, Maryam, Ahangarpour, Akram. (1402). Hepatoprotective effects of Gentisic acid through its anti-oxidant properties in nicotinamide-streptozotocin induced diabetic mice. , 26(12), 1409-1415. doi: 10.22038/ijbms.2023.70659.15359
Reza Noei Razliqi; Elnaz Harooni; Niloofar Neisi; Maryam Jafar Sameri; Akram Ahangarpour. "Hepatoprotective effects of Gentisic acid through its anti-oxidant properties in nicotinamide-streptozotocin induced diabetic mice". , 26, 12, 1402, 1409-1415. doi: 10.22038/ijbms.2023.70659.15359
Noei Razliqi, Reza, Harooni, Elnaz, Neisi, Niloofar, Jafar Sameri, Maryam, Ahangarpour, Akram. (1402). 'Hepatoprotective effects of Gentisic acid through its anti-oxidant properties in nicotinamide-streptozotocin induced diabetic mice', , 26(12), pp. 1409-1415. doi: 10.22038/ijbms.2023.70659.15359
Noei Razliqi, Reza, Harooni, Elnaz, Neisi, Niloofar, Jafar Sameri, Maryam, Ahangarpour, Akram. Hepatoprotective effects of Gentisic acid through its anti-oxidant properties in nicotinamide-streptozotocin induced diabetic mice. , 1402; 26(12): 1409-1415. doi: 10.22038/ijbms.2023.70659.15359

Hepatoprotective effects of Gentisic acid through its anti-oxidant properties in nicotinamide-streptozotocin induced diabetic mice

Iranian Journal of Basic Medical Sciences
مقاله 4، دوره 26، شماره 12، اسفند 2023، صفحه 1409-1415    اصل مقاله (759.6 K)
نوع مقاله: Original Article
شناسه دیجیتال (DOI): 10.22038/ijbms.2023.70659.15359
نویسندگان
Reza Noei Razliqi1؛ Elnaz Harooni1؛ Niloofar Neisi2؛ Maryam Jafar Sameri3؛ Akram Ahangarpour* 4
1Student Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
2Infectious and Tropical Diseases Research Center, Health Research Institute, Department of Medical virology, the School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
3Department of Physiology, Abadan University of Medical Sciences, Abadan, Iran
4Department of Physiology, Persian Gulf Physiology Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
چکیده
Objective(s): Type 2 diabetes mellitus (T2DM) is a common metabolic disorder that causes many complications. Liver failure is one of the complications of T2DM. Oxidative stress plays a major role in the development and progression of T2DM-induced liver injury. Gentisic acid (GA) is a metabolite of aspirin and also a phenolic compound found in natural sources that is a highly effective antioxidant and free radical scavenger. So, in this study, the potential preventive benefits of GA against liver damage induced by T2DM were explored.
Materials and Methods: This study was conducted on 24 adult male mice. T2DM was induced by intraperitoneal injection of a single dose of streptozotocin (at a dose of 65 mg/kg), 15 min after the injection of nicotinamide (at a dose of 120 mg/kg). The grouping was as follows: 1) Normal Control Group; 2) Diabetic Control Group; 3) Positive Control Group: received metformin (150 mg/kg body weight daily) through gavage; 4) Treatment Group: received GA at the dose of 100 mg/kg body weight daily through gavage. Treatments continued for two weeks.
Results: Two weeks of GA treatment in diabetic mice reduced fasting blood glucose, improved plasma levels of hepatic enzymes, and increased liver tissue antioxidant capacity. Histopathological examination revealed that GA administration reduced diabetes-induced liver damage. Furthermore, GA treatment led to the down-regulation of Kelch-like ECH-associated protein 1 (Keap1) and up-regulation of nuclear factor E2-related factor 2 (Nrf2).
Conclusion: The results of this study showed that GA exerts hepatoprotective effects in STZ-induced T2DM mice.
کلیدواژه‌ها
Gentisic acid؛ Liver failure؛ Nuclear factor E2-related- factor 2؛ Oxidative stress؛ Type 2 diabetes mellitus
مراجع
1. Oguntibeju OO. Type 2 diabetes mellitus, oxidative stress and inflammation: Examining the links. Int J Physiol Pathophysiol  Pharmacol 2019; 11:45-63.
2. Younossi ZM. Non-alcoholic fatty liver disease-A global public health perspective. J Hepatol 2019; 70:531-544.
3. Tolman KG, Fonseca V, Dalpiaz A, Tan MH. Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease. Diabetes Care 2007; 30:734-743.
4. Harrison SA. Liver disease in patients with diabetes mellitus. J Clin Gastroenterol 2006; 40:68-76.
5. Ozougwu JC. Physiology of the liver. Int J Res Pharm Biosci 2017; 4:13-24.
6. Gargouri M, Magné C, El Feki A. Hyperglycemia, oxidative stress, liver damage and dysfunction in alloxan-induced diabetic rat are prevented by Spirulina supplementation. Nutr Res 2016; 36:1255-1268.
7. Tonelli C, Chio IIC, Tuveson DA. Transcriptional regulation by Nrf2. Antioxid Redox Signal 2018; 29:1727-1745.
8. Rashid MH, Babu D, Siraki AG. Interactions of the anti-oxidant enzymes NAD (P) H: Quinone oxidoreductase 1 (NQO1) and NRH: Quinone oxidoreductase 2 (NQO2) with pharmacological agents, endogenous biochemicals and environmental contaminants. Chem Biol Interact 2021; 345:109574.
9. Bolignano D, Cernaro V, Gembillo G, Baggetta R, Buemi M, D’Arrigo G. Anti-oxidant agents for delaying diabetic kidney disease progression: A systematic review and meta-analysis. PloS One 2017; 12:e0178699-e0178714.
10. Sehitoglu MH, Han H, Kalin P, Gülçin İ, Ozkan A, Aboul-Enein HY. Pistachio (Pistacia vera L.) Gum: A potent inhibitor of reactive oxygen species. J Enzyme Inhib Med Chem 2015; 30:264-269.
11. Abedi F, Razavi BM, Hosseinzadeh H. A review on gentisic acid as a plant derived phenolic acid and metabolite of aspirin: Comprehensive pharmacology, toxicology, and some pharmaceutical aspects. Phytother Res 2020; 34:729-741.
12. Han X, Guo J, Gao Y, Zhan J, You Y, Huang W. Gentisic acid prevents diet-induced obesity in mice by accelerating the thermogenesis of brown adipose tissue. Food Funct 2021; 12:1262-1270.
13. Razliqi RN, Ahangarpour A, Mard SA, Khorsandi L. Gentisic acid ameliorates type 2 diabetes induced by Nicotinamide-Streptozotocin in male mice by attenuating pancreatic oxidative stress and inflammation through modulation of Nrf2 and NF-кB pathways. Life Sci 2023; 325:121770.
14. Noei Razliqi R, Ahangarpour A, Mard SA, Khorsandi L. Gentisic acid protects against diabetic nephropathy in Nicotinamide-Streptozotocin administered male mice by attenuating oxidative stress and inflammation: The role of miR-200a/Keap1/Nrf2 pathway, renin-angiotensin system (RAS) and NF-кB. Chem Biol Interact 2023; 380:110507.
15. Aamir K, Khan HU, Hossain CF, Afrin MR, Jusuf PR, Waheed I, et al. Arjunolic acid downregulates elevated blood sugar and pro-inflammatory cytokines in streptozotocin (STZ)-nicotinamide induced type 2 diabetic rats. Life Sci 2022; 289:120232.
16. Ahangarpour A, Oroojan AA, Khorsandi L, Kouchak M, Badavi M. Solid lipid nanoparticles of myricitrin have anti-oxidant and antidiabetic effects on streptozotocin-nicotinamide-induced diabetic model and myotube cell of male mouse. Oxid Med Cell Longev 2018;2018:7496936-7496953.
17. Nafees S, Ahmad ST, Arjumand W, Rashid S, Ali N, Sultana S. Modulatory effects of gentisic acid against genotoxicity and hepatotoxicity induced by cyclophosphamide in Swiss albino mice. J Pharm Pharmacol 2012; 64:259-267.
18. Jiang S, Young JL, Wang K, Qian Y, Cai L. Diabetic‑induced alterations in hepatic glucose and lipid metabolism: The role of type 1 and type 2 diabetes mellitus. Mol Med Rep 2020; 22:603-611.
19. Dai B, Wu Q, Zeng C, Zhang J, Cao L, Xiao Z, et al. The effect of Liuwei Dihuang decoction on PI3K/Akt signaling pathway in liver of type 2 diabetes mellitus (T2DM) rats with insulin resistance. J Ethnopharmacol 2016; 192:382-389.
20. Suzuki T, Yamamoto M. Molecular basis of the Keap1–Nrf2 system. Free Radic Biol Med 2015; 88:93-100.
21. Tong Y-H, Zhang B, Yan Y-Y, Fan Y, Yu J-W, Kong S-S, et al. Dual-negative expression of Nrf2 and NQO1 predicts superior outcomes in patients with non-small cell lung cancer. Oncotarget 2017; 8:45750-45758.
22. König M, Bulik S, Holzhütter H-G. Quantifying the contribution of the liver to glucose homeostasis: A detailed kinetic model of human hepatic glucose metabolism. PLoS Comput Biol 2012; 8:e1002577-1002593.
23. Kume E, Aruga C, Takahashi K, Miwa S, Dekura E, Itoh M, et al. Morphological and gene expression analysis in mouse primary cultured hepatocytes exposed to streptozotocin. Exp Toxicol Pathol 2005; 56:245-253.
24. Samadi‐Noshahr Z, Hadjzadeh MAR, Moradi‐Marjaneh R, Khajavi‐Rad A. The hepatoprotective effects of fennel seeds extract and trans‐Anethole in streptozotocin‐induced liver injury in rats. Food Sci Nutr 2021; 9:1121-1131.
25. McGill MR. The past and present of serum aminotransferases and the future of liver injury biomarkers. EXCLI J 2016; 15:817-828.
26. Ghimire S, Shakya S, Shakya J, Acharya P, Pardhe B. Abnormal liver parameters among individuals with type 2 diabetes mellitus Nepalese population. Biochem Pharmacol 2018; 7:1-5.
27. Ramachandran V, Saravanan R. Asiatic acid prevents lipid peroxidation and improves anti-oxidant status in rats with streptozotocin-induced diabetes. J Funct Foods 2013; 5:1077-1087.
28. Sharma U, Pal D, Prasad R. Alkaline phosphatase: An overview. Indian J Clin Biochem 2014; 29:269-278.
29. Jing ZY, Lei SH, Teng W, Xin LX, Chang L, Fang S, et al. Pterostilbene ameliorates glycemic control, dyslipidemia and liver injury in type 2 diabetes rats. Biomed Environ Sci 2020; 33:365-368.
30. Aristatile B, Al‐Numair KS, Veeramani C, Pugalendi KV. Effect of carvacrol on hepatic marker enzymes and anti-oxidant status in d‐galactosamine‐induced hepatotoxicity in rats. Fundam Clin Pharmacol 2009; 23:757-765.
31. Bhakkiyalakshmi E, Sireesh D, Sakthivadivel M, Sivasubramanian S, Gunasekaran P, Ramkumar KM. Anti-hyperlipidemic and anti-peroxidative role of pterostilbene via Nrf2 signaling in experimental diabetes. Eur J Pharmacol 2016; 777:9-16.
32. Lucchesi AN, Cassettari LL, Spadella CT. Alloxan-induced diabetes causes morphological and ultrastructural changes in rat liver that resemble the natural history of chronic fatty liver disease in humans. J Diabetes Res 2015; 2015:494578-494588.
33. Watanabe S, Okoshi H, Yamabe S, Shimada M. Moringa oleifera Lam. in diabetes mellitus: A systematic review and meta-analysis. Molecules 2021; 26:3513-3530.
34. Su RC, Lad A, Breidenbach JD, Blomquist TM, Gunning WT, Dube P, et al. Hyperglycemia induces key genetic and phenotypic changes in human liver epithelial HepG2 cells which parallel the Leprdb/J mouse model of non-alcoholic fatty liver disease (NAFLD). PLoS One 2019; 14:e0225604-225620.
35. Dludla PV, Nkambule BB, Mazibuko-Mbeje SE, Nyambuya TM, Marcheggiani F, Cirilli I, et al. N-acetyl cysteine targets hepatic lipid accumulation to curb oxidative stress and inflammation in NAFLD: A comprehensive analysis of the literature. Antioxidants 2020; 9:1283-1302.
36. Madduma Hewage S, Prashar S, O K, Siow YL. Lingonberry improves non-alcoholic fatty liver disease by reducing hepatic lipid accumulation, oxidative stress and inflammatory response. Antioxidants 2021; 10:565-579.
37. Chen J, Ding X, Wu R, Tong B, Zhao L, Lv H, et al. Novel sesquiterpene glycoside from loquat leaf alleviates type 2 diabetes mellitus combined with nonalcoholic fatty liver disease by improving insulin resistance, oxidative stress, inflammation, and gut microbiota composition. J Agric Food Chem 2021; 69:14176-14191.
38. Mohamed J, Nazratun Nafizah AH, Zariyantey AH, Budin SB. Mechanisms of Diabetes-Induced Liver Damage: The role of oxidative stress and inflammation. Sultan Qaboos Univ Med J 2016; 16:e132-141.
39. Sameri MJ, Savari F, Hoseinynejad K, Danyaei A, Mard SA. The hepato-protective effect of H2S-modified and non-modified mesenchymal stem cell exosomes on liver ischemia-reperfusion injury in mice: The role of MALAT1. Biochem Biophys Res Commun 2022; 635:194-202.
40. Jafar Sameri M, Belali R, Neisi N, Noei Razliqi R, Mard SA, Savari F, et al. Sodium Hydrosulfide modification of mesenchymal stem cell-exosomes improves liver function in CCL4-induced hepatic injury in mice. Rep Biochem Mol Biol 2023; 11:644-655.
41. Volpe CMO, Villar-Delfino PH, Dos Anjos PMF, Nogueira-Machado JA. Cellular death, reactive oxygen species (ROS) and diabetic complications. Cell Death Dis 2018; 9:119-127.
42. Radmehr V, Ahangarpour A, Mard SA, Khorsandi L. Crocin attenuates endoplasmic reticulum stress in methylglyoxal-induced diabetic nephropathy in male mice: MicroRNAs alterations and glyoxalase 1-Nrf2 signaling pathways. Iran J Basic Med Sci 2022; 25:1341-1348.
43. Ebrahimian Z, Razavi BM, Mousavi Shaegh SA, Hosseinzadeh H. Effects of Portulaca oleracea L. (purslane) on the metabolic syndrome: A review. Iran J Basic Med Sci 2022; 25:1275-1285.
44. Salaramoli S, Mehri S, Yarmohammadi F, Hashemy SI, Hosseinzadeh H. The effects of ginger and its constituents in the prevention of metabolic syndrome: A review. Iran J Basic Med Sci 2022; 25:664-674.
45. Mahmoud AM, Hussein OE, Hozayen WG, Bin-Jumah M, Abd El-Twab SM. Ferulic acid prevents oxidative stress, inflammation, and liver injury via upregulation of Nrf2/HO-1 signaling in methotrexate-induced rats. Environ Sci Pollut Res 2020; 27:7910-7921.
46. Yan C, Zhang Y, Zhang X, Aa J, Wang G, Xie Y. Curcumin regulates endogenous and exogenous metabolism via Nrf2-FXR-LXR pathway in NAFLD mice. Biomed Pharmacother 2018; 105:274-281.
47. Yeh C-T, Yen G-C. Induction of hepatic anti-oxidant enzymes by phenolic acids in rats is accompanied by increased levels of multidrug resistance-associated protein 3 mRNA expression. J Nutr 2006; 136:11-15.
48. Samaha MM, Said E, Salem HA. A comparative study of the role of crocin and sitagliptin in attenuation of STZ-induced diabetes mellitus and the associated inflammatory and apoptotic changes in pancreatic β-islets. Environ Toxicol Pharmacol 2019; 72:103238.
49. Margaritis I, Angelopoulou K, Lavrentiadou S, Mavrovouniotis IC, Tsantarliotou M, Taitzoglou I, et al. Effect of crocin on anti-oxidant gene expression, fibrinolytic parameters, redox status and blood biochemistry in nicotinamide-streptozotocin-induced diabetic rats. J Biol Res 2020; 27:4-18.
50. Hamden K, Carreau S, Boujbiha MA, Lajmi S, Aloulou D, Kchaou D, et al. Hyperglycaemia, stress oxidant, liver dysfunction and histological changes in diabetic male rat pancreas and liver: Protective effect of 17β-estradiol. Steroids 2008; 73:495-501.

آمار
تعداد مشاهده مقاله: 1,011
تعداد دریافت فایل اصل مقاله: 583